Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €18.78 EUR
Change Today +0.022 / 0.12%
Volume 447.0
M3V On Other Exchanges
As of 3:35 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

mevis medical solutions ag (M3V) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/11/15 - €19.89
52 Week Low
10/16/14 - €12.38
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MEVIS MEDICAL SOLUTIONS AG (M3V)

Related News

No related news articles were found.

mevis medical solutions ag (M3V) Related Businessweek News

No Related Businessweek News Found

mevis medical solutions ag (M3V) Details

MeVis Medical Solutions AG, together with its subsidiaries, develops, markets, and sells software for analyzing and evaluating image data to equipment manufacturers of medical devices and providers of medical IT platforms. Its clinical focuses include image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, prostate, and colon cancers, as well as neurological disorders. It operates in two segments, Digital Mammography and Other Diagnostics. The Digital Mammography segment develops and markets software products, which support breast diagnostic imaging and intervention. This segment also offers software applications for imaging techniques and digital mammography, such as ultrasound, magnetic resonance imaging, and tomosynthesis. The Other Diagnostics segment provides digital radiology products, including magnetic resonance imaging and computer tomography for diseases, such as lung, prostate, and intestinal disorders, as well as general image-based analysis and diagnostics of radiology images. This segment also offers image and risk analysis for planning liver surgery and tumor diagnostics in connection with clinical studies of pharmaceutical companies. The company has operations in the United States, Europe, and internationally. MeVis Medical Solutions AG was founded in 1992 and is based in Bremen, Germany.

93 Employees
Last Reported Date: 11/17/14
Founded in 1992

mevis medical solutions ag (M3V) Top Compensated Officers

Chairman of the Executive Board and Chief Exe...
Total Annual Compensation: €306.3K
Chief Financial Officer and Member of Executi...
Total Annual Compensation: €243.4K
Compensation as of Fiscal Year 2013.

mevis medical solutions ag (M3V) Key Developments

Mevis Medical Solutions Announces Supervisory Board Changes

Prof. Dr. Heinz-Otto Peitgen, Chairman of the Supervisory Board of MeVis Medical Solutions AG, and Mr. Peter Kuhlmann-Lehmkuhle, Member of the Supervisory Board of MeVis Medical Solutions AG, informed the company that, in light of the acquisition of a majority stake in the company by VMS Deutschland Holdings GmbH, they will resign from their respective offices effective as of the end of the Annual General Meeting on June 9, 2015. The Supervisory Board has decided to propose Mr. Jörg Fässler and Mr. Glen Hilton, both in responsible executive positions at Varian Medical Systems, as Members of the Supervisory Board at the Annual General Meeting on June 9, 2015. Dr. Jens Kruse will remain a Member of the Supervisory Board.

MeVis Medical Solutions AG Reports Preliminary Earnings Results for the Fiscal Year 2014; Provides Earnings Guidance for 2015

MeVis Medical Solutions AG reported preliminary earnings results for the fiscal year 2014. For the period, the company reported revenues of EUR 13.1 million up 2 % compared to the previous year's revenues of EUR 12.8 million. The increase in revenues resulted entirely from the Digital Mammography segment, where revenues rose from EUR 9.4 million to EUR 9.8 million, while revenues in the Other Diagnostics segment declined marginally from EUR 3.4 million to EUR 3.3 million. EBIT (earnings before interest and taxes) of EUR 3.9 million, which is EUR 0.5 million lower than the previous year. For 2015, The company expects revenues between EUR 13.0 and EUR 13.5 m. The company anticipates a significant drop in EBIT to EUR 2.0 million to EUR 2.5 million. In addition to a slight increase in operating costs this is primarily due to the termination of capitalization of development costs and a slight increase in depreciation.

MeVis Medical Solutions AG Revises Earnings Guidance for the Fiscal Year of 2014

MeVis Medical Solutions AG revises earnings guidance for the fiscal year of 2014. For the year 2014, the company revenues are expected to remain stable at between EUR 12.5 and EUR 13.0 million compared to previous forecast to slight decline in revenues to between EUR 12.0 and 12.5 million. For the EBIT (earnings before interest and taxes), a slight decrease over the previous year continues to be expected, at EUR 3.5 to EUR 4.0 million compared to previous forecast of EBIT between EUR 3.0 and 3.5 million. For the end of 2014 another increase in liquidity is expected to now EUR 16.5 to EUR 17.5 million due to a continued positive cash flow compared to previous forecast of EUR 15.0 to EUR 16.0 million. The company raises its forecast for the present fiscal year due to the current business development.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
M3V:GR €18.78 EUR +0.022

M3V Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for M3V.
View Industry Companies

Industry Analysis


Industry Average

Valuation M3V Industry Range
Price/Earnings 6.7x
Price/Sales 1.7x
Price/Book 0.9x
Price/Cash Flow 4.7x
TEV/Sales 0.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEVIS MEDICAL SOLUTIONS AG, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at